Assay ID | Title | Year | Journal | Article |
AID1759442 | Hemolytic activity in human RBC at 8 ug/ml incubated for 30 mins | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759460 | Antifungal activity against Aspergillus niger incubated for 48 hrs by broth microdilution method | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID680138 | TP_TRANSPORTER: inhibition of Calcein-AM efflux (Calcein-AM: 0.25 uM) in CEM/VLB100 cells | 2000 | Journal of medicinal chemistry, Jun-29, Volume: 43, Issue:13
| Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter. |
AID1759436 | Antifungal activity against Cryptococcus neoformans PFCC 93-589 after 7 days in presence of sorbitol by microdilution assay | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759426 | Synergistic antifungal activity against Cryptococcus neoformans PFCC 93-589 assessed as fractional inhibitory concentration index in presence of fluconazole by checkerboard microtiter assay | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759431 | Inhibition of ergosterol biosynthesis in Cryptococcus neoformans PFCC 93-589 cell membrane assessed as ergosterol content at 1 times MIC incubated for 48 hrs by UV-visible spectrophotometric analysis (Rvb = 0.134 No_unit) | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1233883 | Antifungal activity against Aspergillus fumigatus by broth dilution method | 2015 | ACS medicinal chemistry letters, Jun-11, Volume: 6, Issue:6
| Generation of Broad-Spectrum Antifungal Drug Candidates from the Natural Product Compound Aureobasidin A. |
AID1759466 | Antifungal activity against Candida parapsilosis incubated for 24 hrs by broth microdilution method | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759433 | Antifungal activity against Cryptococcus neoformans PFCC 93-589 after 2 days in absence of sorbitol by microdilution assay | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID542406 | Inhibition of Saccharomyces cerevisiae SJ21R inositol phosphorylceramide synthase preincubated for 30 mins | 2009 | Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
| Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. |
AID542412 | Inhibition of Aspergillus fumigatus inositol phosphorylceramide synthase | 2009 | Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
| Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. |
AID1759467 | Antifungal activity against Candida krusei incubated for 24 hrs by broth microdilution method | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID542416 | Irreversible inhibition of Saccharomyces cerevisiae SJ21R inositol phosphorylceramide synthase preincubated for 30 mins | 2009 | Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
| Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. |
AID1759451 | Cytotoxicity against human HEK293 cells assessed as inhibition of cell viability at 2 times MIC incubated for 24 hrs by MTT assay | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759468 | Antifungal activity against Cryptococcus neoformans PFCC 93-589 assessed as half minimum inhibitory concentration by broth microdilution assay | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759461 | Antifungal activity against Aspergillus fumigatus incubated for 48 hrs by broth microdilution method | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID542408 | Noncompetitive inhibition of aureobasidin A-resistant Saccharomyces cerevisiae inositol phosphorylceramide synthase preincubated for 30 mins by Michaelis-Menten plot | 2009 | Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
| Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. |
AID1759453 | Induction of morphological changes in Cryptococcus neoformans PFCC 93-589 assessed as deposition of lipid globules at 2 ug/ml after 48 hrs by TEM analysis | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759450 | Cytotoxicity against human HEK293 cells assessed as cell survival at 1 times MIC incubated for 24 hrs by MTT assay | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759428 | Induction of morphological changes in Cryptococcus neoformans PFCC 93-589 assessed as disorganization of cytoplasmic content at 2 ug/ml after 48 hrs by TEM analysis | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID542409 | Inhibition of Saccharomyces cerevisiae SJ21R inositol phosphorylceramide synthase | 2009 | Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
| Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. |
AID1759437 | Antifungal activity against Cryptococcus neoformans PFCC 93-589 assessed as increase in extracellular potassium leakage at 2 times MIC incubated up to 12 hrs measured per mg dry weight of cell by spectrophotometric method | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID554742 | Inhibition of Candida krusei ABC1 expressed in Saccharomyces cerevisiae isolate ADdelta at 7 nM | 2009 | Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
| Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei. |
AID1759465 | Antifungal activity against Candida tropicalis incubated for 24 hrs by broth microdilution method | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID542410 | Inhibition of Candida albicans inositol phosphorylceramide synthase | 2009 | Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
| Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. |
AID1759441 | Antifungal activity against Cryptococcus neoformans PFCC 93-589 assessed as TOS production at 2 times MIC incubated for 10 mins measured per mg of protein by colorimetric method (Rvb = 1.63 umol) | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759438 | Antifungal activity against Cryptococcus neoformans PFCC 93-589 assessed as inhibition of melanin production at 0.5 times MIC incubated for 2 to 10 days | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759464 | Antifungal activity against Candida glabrata incubated for 24 hrs by broth microdilution method | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759427 | Antifungal activity against Cryptococcus neoformans PFCC 93-589 by broth microdilution assay | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID542415 | Irreversible inhibition of Candida albicans ATCC 38247 inositol phosphorylceramide synthase | 2009 | Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
| Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. |
AID1759462 | Antifungal activity against Aspergillus flavus incubated for 48 hrs by broth microdilution method | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759445 | Hemolytic activity in human RBC at 1 ug/ml incubated for 30 mins | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759463 | Antifungal activity against Candida albicans incubated for 24 hrs by broth microdilution method | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759435 | Antifungal activity against Cryptococcus neoformans PFCC 93-589 after 7 days in absence of sorbitol by microdilution assay | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759440 | Antifungal activity against Cryptococcus neoformans PFCC 93-589 assessed as TOS production at 1 times MIC incubated for 10 mins measured per mg of protein by colorimetric method (Rvb = 1.19 umol) | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759469 | Antifungal activity against Cryptococcus neoformans PFCC 93-589 in presence of fluconazole by checkerboard microtiter assay | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1233919 | Time dependent inhibition of Candida albicans ATCC 38247 membrane inositol phosphorylceramide synthase using ceramide as substrate | 2015 | ACS medicinal chemistry letters, Jun-11, Volume: 6, Issue:6
| Generation of Broad-Spectrum Antifungal Drug Candidates from the Natural Product Compound Aureobasidin A. |
AID542404 | Inhibition of Candida albicans ATCC 38247 inositol phosphorylceramide synthase | 2009 | Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
| Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. |
AID542405 | Inhibition of Candida albicans ATCC 38247 inositol phosphorylceramide synthase preincubated for 30 mins | 2009 | Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
| Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. |
AID542407 | Inhibition of aureobasidin A-resistant Saccharomyces cerevisiae inositol phosphorylceramide synthase preincubated for 30 mins | 2009 | Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
| Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. |
AID1759456 | Upregulation of Lac1 gene expression in Cryptococcus neoformans PFCC 93-589 assessed as fold increase in protein level at 2 ug/ml by SYBR green based RT-PCR analysis | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759446 | Hemolytic activity in human RBC at 0.5 ug/ml incubated for 30 mins | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759449 | Cytotoxicity against human HEK293 cells assessed as cell survival at 0.5 times MIC incubated for 24 hrs by MTT assay | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759425 | Fungicidal activity against Cryptococcus neoformans PFCC 93-589 by broth microdilution assay | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1233882 | Antifungal activity against Candida albicans by broth dilution method | 2015 | ACS medicinal chemistry letters, Jun-11, Volume: 6, Issue:6
| Generation of Broad-Spectrum Antifungal Drug Candidates from the Natural Product Compound Aureobasidin A. |
AID542411 | Inhibition of Saccharomyces cerevisiae inositol phosphorylceramide synthase | 2009 | Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
| Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. |
AID1759448 | Cytotoxicity against human HEK293 cells assessed as cell survival at 0.25 times MIC incubated for 24 hrs by MTT assay | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759429 | Inhibition of ergosterol biosynthesis in Cryptococcus neoformans PFCC 93-589 cell membrane assessed as ergosterol content at 0.5 times MIC incubated for 48 hrs by UV-visible spectrophotometric analysis (Rvb = 0.134 No_unit) | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759439 | Antifungal activity against Cryptococcus neoformans PFCC 93-589 assessed as TOS production at 0.5 times MIC incubated for 10 mins measured per mg of protein by colorimetric method (Rvb = 1.04 umol) | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759434 | Antifungal activity against Cryptococcus neoformans PFCC 93-589 after 2 days in presence of sorbitol by microdilution assay | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759452 | Induction of morphological changes in Cryptococcus neoformans PFCC 93-589 assessed as excessive vacuolization at 2 ug/ml after 48 hrs by TEM analysis | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759430 | Inhibition of ergosterol biosynthesis in Cryptococcus neoformans PFCC 93-589 cell membrane at 0.5 times MIC incubated for 48 hrs by UV-visible spectrophotometric analysis | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759432 | Inhibition of ergosterol biosynthesis in Cryptococcus neoformans PFCC 93-589 cell membrane at 1 times MIC incubated for 48 hrs by UV-visible spectrophotometric analysis | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759457 | Downregulation of Cxt1p gene expression in Cryptococcus neoformans PFCC 93-589 assessed as fold decrease in protein level at 2 ug/ml by SYBR green based RT-PCR analysis | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759443 | Hemolytic activity in human RBC at 4 ug/ml incubated for 30 mins | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759471 | Downregulation of Cxt1p gene expression in Cryptococcus neoformans PFCC 93-589 at 2 ug/ml by SYBR green based RT-PCR analysis relative to control | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
AID1759444 | Hemolytic activity in human RBC at 2 ug/ml incubated for 30 mins | 2021 | Bioorganic & medicinal chemistry letters, 06-01, Volume: 41 | Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |